Cargando…

Possible agent for COVID-19 treatment: Rifampicin

Rifampicin is a promising drug for the treatment of coronavirus disease 2019 based on its antiviral properties and recent in silico studies. In silico studies can serve as a foundation for further studies.

Detalles Bibliográficos
Autores principales: Aydin, Ozlem Celik, Aydın, Sonay, Barun, Sureyya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9523331/
https://www.ncbi.nlm.nih.gov/pubmed/36188747
http://dx.doi.org/10.5501/wjv.v11.i5.391

Ejemplares similares